FitzPatrick Margaret M made one open market purchase of AN2 Therapeutics, Inc. ($ANTX) shares in the last year, totaling about $10,100, with the most recent on May 28, 2025. Her activity ranks 4,264th among 4,983 insiders in our database, where the average purchase is $1.46 million across 3.29 transactions. She reported no open market sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 19, 2026 | AN2 Therapeutics, Inc. | $ANTX | FitzPatrick Margaret M | Not found | A | Stock Option (right to buy) | 11463 | $0.00 | 11,463.0000 | 30,276,230 | 9999.99% | 0.04% |
| March 19, 2026 | AN2 Therapeutics, Inc. | $ANTX | FitzPatrick Margaret M | Not found | D | Stock Option (right to buy) | 23742 | $0.00 | 0.0000 | 30,276,230 | 100.00% | 0.08% |
| March 19, 2026 | AN2 Therapeutics, Inc. | $ANTX | FitzPatrick Margaret M | Not found | A | Stock Option (right to buy) | 23742 | $0.00 | 23,742.0000 | 30,276,230 | 9999.99% | 0.08% |
| March 19, 2026 | AN2 Therapeutics, Inc. | $ANTX | FitzPatrick Margaret M | Not found | D | Stock Option (right to buy) | 10362 | $0.00 | 0.0000 | 30,276,230 | 100.00% | 0.03% |
| March 19, 2026 | AN2 Therapeutics, Inc. | $ANTX | FitzPatrick Margaret M | Not found | A | Stock Option (right to buy) | 10362 | $0.00 | 10,362.0000 | 30,276,230 | 9999.99% | 0.03% |
| March 19, 2026 | AN2 Therapeutics, Inc. | $ANTX | FitzPatrick Margaret M | Not found | D | Stock Option (right to buy) | 11463 | $0.00 | 0.0000 | 30,276,230 | 100.00% | 0.04% |
| Feb. 20, 2026 | AN2 Therapeutics, Inc. | $ANTX | FitzPatrick Margaret M | Not found | A | Stock Option (Right to Buy) | 20400 | $0.00 | 20,400.0000 | 30,276,230 | 9999.99% | 0.07% |
| Sept. 9, 2025 | Vistagen Therapeutics, Inc. | $VTGN | FitzPatrick Margaret M | Director | A | Non-Qualified Stock Option (right to buy) | 17600 | $0.00 | 17,600.0000 | 29,157,733 | 9999.99% | 0.06% |
| May 28, 2025 | AN2 Therapeutics, Inc. | $ANTX | FitzPatrick Margaret M | Not found | P | Common Stock | 8610 | $1.18 | 8,610.0000 | 29,828,227 | 9999.99% | 0.03% |
| May 22, 2025 | AN2 Therapeutics, Inc. | $ANTX | FitzPatrick Margaret M | Not found | A | Stock Option (Right to Buy) | 19111 | $0.00 | 19,111.0000 | 29,828,227 | 9999.99% | 0.06% |
| Sept. 6, 2024 | Vistagen Therapeutics, Inc. | $VTGN | FitzPatrick Margaret M | Not found | A | Stock Option (Right to Buy) | 14100 | $0.00 | 14,100.0000 | 19,354,500 | 9999.99% | 0.07% |
| June 19, 2024 | AN2 Therapeutics, Inc. | $ANTX | FitzPatrick Margaret M | Not found | A | Stock Option (Right to Buy) | 64503 | $0.00 | 64,503.0000 | 23,600,107 | 9999.99% | 0.27% |
| March 4, 2024 | Vistagen Therapeutics, Inc. | $VTGN | FitzPatrick Margaret M | Not found | A | Stock Option (Right to Buy) | 12500 | $0.00 | 12,500.0000 | 0 | 9999.99% | 0.00% |
| June 7, 2023 | AN2 Therapeutics, Inc. | $ANTX | FitzPatrick Margaret M | Director | A | Stock Option (right to buy) | 23742 | $0.00 | 23,742.0000 | 0 | 9999.99% | 0.00% |